Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from May 1 2025. Pharmac’s Director ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Recent decades have seen a lot of progress in diabetes treatment. In a new study, Per-Ola Carlsson, Professor of Medical Cell Biology, has obtained promising results. "This is the first time anyone ...

Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from 1 May 2025. Pharmac’s Director Pharmaceuticals, Geraldine MacGibbon, expects about 13,000 people with ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin degludec) got US approval late last year. [caption id ...

Elderly and disabled people are encountering severe service disruptions as the Trump administration overhauls the Social ...

Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

Bill Trotter's children say he was misdiagnosed at Cumberland Infirmary - and claim a failure to fit a catheter could have ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...